Charles K. Gayer is CCO at BIOCRYST PHARMACEUTICALS INC (BCRX). They have made 2 open-market trades across 1 company since 2022, most recently 2025-12-22.
CIK 0001800110
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $164K since 2024, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCRX | 902,583 | $7.0M |
Shares reported on the most recent Form 4, priced at the 2025-12-23 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.